Literature DB >> 17898072

Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity.

Eric Bergeron1, Martin J Vincent, Stuart T Nichol.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) causes severe human disease. The CCHFV medium RNA encodes a polyprotein which is proteolytically processed to yield the glycoprotein precursors PreGn and PreGc, followed by structural glycoproteins Gn and Gc. Subtilisin kexin isozyme-1/site-1 protease (SKI-1/S1P) plays a central role in Gn processing. Here we show that CCHFV-infected cells deficient in SKI-1/S1P produce no infectious virus, although PreGn and PreGc accumulated normally in the Golgi apparatus, the site of virus assembly. Only nucleoprotein-containing particles which lacked virus glycoproteins (Gn/Gc or PreGn/PreGc) were secreted. Complementation of SKI-1/S1P-deficient cells with a SKI-1/S1P expression vector restored release of infectious virus (>10(6) PFU/ml), confirming that SKI-1/S1P processing is required for incorporation of viral glycoproteins. SKI-1/S1P may represent a promising antiviral target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17898072      PMCID: PMC2169102          DOI: 10.1128/JVI.01647-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA.

Authors:  C Löber; B Anheier; S Lindow; H D Klenk; H Feldmann
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

Review 2.  Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis.

Authors:  Joseph L Goldstein; Robert B Rawson; Michael S Brown
Journal:  Arch Biochem Biophys       Date:  2002-01-15       Impact factor: 4.013

3.  Reverse genetics demonstrates that proteolytic processing of the Ebola virus glycoprotein is not essential for replication in cell culture.

Authors:  Gabriele Neumann; Heinz Feldmann; Shinji Watanabe; Igor Lukashevich; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

Authors:  O Lenz; J ter Meulen; H D Klenk; N G Seidah; W Garten
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

5.  Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus.

Authors:  Angela J Sanchez; Martin J Vincent; Stuart T Nichol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

6.  Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein.

Authors:  Louis A Altamura; Andrea Bertolotti-Ciarlet; Jeffrey Teigler; Jason Paragas; Connie S Schmaljohn; Robert W Doms
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

7.  Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture.

Authors:  Tanja Strive; Eva Borst; Martin Messerle; Klaus Radsak
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

8.  ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs.

Authors:  J Ye; R B Rawson; R Komuro; X Chen; U P Davé; R Prywes; M S Brown; J L Goldstein
Journal:  Mol Cell       Date:  2000-12       Impact factor: 17.970

9.  Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins.

Authors:  Sonja R Gerrard; Stuart T Nichol
Journal:  Virology       Date:  2006-09-08       Impact factor: 3.616

Review 10.  Crimean-Congo haemorrhagic fever.

Authors:  Onder Ergönül
Journal:  Lancet Infect Dis       Date:  2006-04       Impact factor: 25.071

View more
  34 in total

1.  Creation of a nonspreading Rift Valley fever virus.

Authors:  Jeroen Kortekaas; Nadia Oreshkova; Viviana Cobos-Jiménez; Rianka P M Vloet; Christiaan A Potgieter; Rob J M Moormann
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

2.  A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.

Authors:  Stephanie Devignot; Eric Bergeron; Stuart Nichol; Ali Mirazimi; Friedemann Weber
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

3.  Therapeutic intervention in Crimean-Congo hemorrhagic fever: where are we now?

Authors:  Jessica R Spengler; Dennis A Bente
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

4.  Mapping of the interaction domains of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein.

Authors:  Jesica M Levingston Macleod; Hannah Marmor; Adolfo García-Sastre; Natalia Frias-Staheli
Journal:  J Gen Virol       Date:  2014-11-11       Impact factor: 3.891

5.  Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner.

Authors:  Daniel L Popkin; John R Teijaro; Brian M Sullivan; Shuzo Urata; Sophie Rutschmann; Juan Carlos de la Torre; Stefan Kunz; Bruce Beutler; Michael Oldstone
Journal:  Cell Host Microbe       Date:  2011-03-17       Impact factor: 21.023

Review 6.  Proprotein convertase inhibition: Paralyzing the cell's master switches.

Authors:  Andres J Klein-Szanto; Daniel E Bassi
Journal:  Biochem Pharmacol       Date:  2017-04-27       Impact factor: 5.858

7.  Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing.

Authors:  César G Albariño; Eric Bergeron; Bobbie Rae Erickson; Marina L Khristova; Pierre E Rollin; Stuart T Nichol
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

8.  Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agents.

Authors:  Andrea D Olmstead; Wolfgang Knecht; Ina Lazarov; Surjit B Dixit; François Jean
Journal:  PLoS Pathog       Date:  2012-01-05       Impact factor: 6.823

9.  Kupe virus, a new virus in the family bunyaviridae, genus nairovirus, kenya.

Authors:  Mary B Crabtree; Rosemary Sang; Barry R Miller
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

10.  Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.

Authors:  Anna Maisa; Ute Ströher; Hans-Dieter Klenk; Wolfgang Garten; Thomas Strecker
Journal:  PLoS Negl Trop Dis       Date:  2009-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.